News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Editas Medicine
NEWS
JOBS
IN THE PRESS
AWARDS
NEWS
Drug Development
CRISPR, Editas Medicine and Intellia Fall as Scientific Paper Warns of Unintended Mutations Linked to Gene-Editing
May 31, 2017
·
3 min read
Business
Is Editas Medicine Facing A New Reality In CRISPR Land?
May 17, 2017
·
1 min read
Business
Editas Medicine, Veritas Genetics Co-Founder and Biotech Phenom George Church Makes Time’s 100 ‘Most Influential’ List
April 21, 2017
·
2 min read
Business
Turns Out Editas Medicine’s R&D Deal With Allergan Could be Worth $1 Billion
March 23, 2017
·
3 min read
Business
Third Rock Ventures Quietly Launches Tango Therapeutics in Editas Medicine’s HQ
March 7, 2017
·
2 min read
Business
COO and First Employee of Editas Medicine to Exit, Effective March 31
March 6, 2017
·
2 min read
Business
Editas Medicine Brings on New Execs From Sanofi Genzyme, Novartis AG, Baxalta and Bristol-Myers Squibb
October 5, 2016
·
2 min read
Biotech Bay
10 Biotech Stocks Analysts are Upbeat About in May
May 23, 2016
·
3 min read
Bio NC
Top 5 Biotech Winners and Losers of Q1 2016
March 31, 2016
·
3 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Editas Medicine Announces Updated Presentation Time for Upcoming Investor Conference
May 29, 2026
·
1 min read
Press Releases
Editas Medicine Announces Pricing of Up to $319.4 Million Public Offering
May 26, 2026
·
5 min read
Press Releases
Editas Medicine Presents EDIT-401 Preclinical Data Demonstrating Robust Reductions in LDL-C, Lp(a), and ApoB in Non-Human Primates at the 94th European Atherosclerosis Society Congress
May 26, 2026
·
5 min read
Press Releases
Editas Medicine Announces Proposed Public Offering - May 26, 2026
May 26, 2026
·
4 min read
Press Releases
Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting
May 14, 2026
·
6 min read
Press Releases
Editas Medicine Announces First Quarter 2026 Results and Business Updates
May 5, 2026
·
10 min read
Press Releases
Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences
April 28, 2026
·
3 min read
Press Releases
Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference
March 27, 2026
·
4 min read
Press Releases
Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates
March 9, 2026
·
10 min read
Press Releases
Editas Medicine to Participate in Upcoming March 2026 Investor Conferences
February 23, 2026
·
1 min read
